321 related articles for article (PubMed ID: 12826680)
1. The CD44 alternative v9 exon contains a splicing enhancer responsive to the SR proteins 9G8, ASF/SF2, and SRp20.
Galiana-Arnoux D; Lejeune F; Gesnel MC; Stevenin J; Breathnach R; Del Gatto-Konczak F
J Biol Chem; 2003 Aug; 278(35):32943-53. PubMed ID: 12826680
[TBL] [Abstract][Full Text] [Related]
2. hnRNP A1 and the SR proteins ASF/SF2 and SC35 have antagonistic functions in splicing of beta-tropomyosin exon 6B.
Expert-Bezançon A; Sureau A; Durosay P; Salesse R; Groeneveld H; Lecaer JP; Marie J
J Biol Chem; 2004 Sep; 279(37):38249-59. PubMed ID: 15208309
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of the SR proteins 9G8, SC35, ASF/SF2, and SRp40 on the utilization of the A1 to A5 splicing sites of HIV-1 RNA.
Ropers D; Ayadi L; Gattoni R; Jacquenet S; Damier L; Branlant C; Stévenin J
J Biol Chem; 2004 Jul; 279(29):29963-73. PubMed ID: 15123677
[TBL] [Abstract][Full Text] [Related]
4. Regulation of SRp20 exon 4 splicing.
Jumaa H; Nielsen PJ
Biochim Biophys Acta; 2000 Nov; 1494(1-2):137-43. PubMed ID: 11072076
[TBL] [Abstract][Full Text] [Related]
5. SR proteins Asf/SF2 and 9G8 interact to activate enhancer-dependent intron D splicing of bovine growth hormone pre-mRNA in vitro.
Li X; Shambaugh ME; Rottman FM; Bokar JA
RNA; 2000 Dec; 6(12):1847-58. PubMed ID: 11142383
[TBL] [Abstract][Full Text] [Related]
6. The SR splicing factors ASF/SF2 and SC35 have antagonistic effects on intronic enhancer-dependent splicing of the beta-tropomyosin alternative exon 6A.
Gallego ME; Gattoni R; Stévenin J; Marie J; Expert-Bezançon A
EMBO J; 1997 Apr; 16(7):1772-84. PubMed ID: 9130721
[TBL] [Abstract][Full Text] [Related]
7. Selection and characterization of pre-mRNA splicing enhancers: identification of novel SR protein-specific enhancer sequences.
Schaal TD; Maniatis T
Mol Cell Biol; 1999 Mar; 19(3):1705-19. PubMed ID: 10022858
[TBL] [Abstract][Full Text] [Related]
8. Binding sites for Rev and ASF/SF2 map to a 55-nucleotide purine-rich exonic element in equine infectious anemia virus RNA.
Chung H ; Derse D
J Biol Chem; 2001 Jun; 276(22):18960-7. PubMed ID: 11278454
[TBL] [Abstract][Full Text] [Related]
9. The splicing factors 9G8 and SRp20 transactivate splicing through different and specific enhancers.
Cavaloc Y; Bourgeois CF; Kister L; Stévenin J
RNA; 1999 Mar; 5(3):468-83. PubMed ID: 10094314
[TBL] [Abstract][Full Text] [Related]
10. Identification of a bidirectional splicing enhancer: differential involvement of SR proteins in 5' or 3' splice site activation.
Bourgeois CF; Popielarz M; Hildwein G; Stevenin J
Mol Cell Biol; 1999 Nov; 19(11):7347-56. PubMed ID: 10523623
[TBL] [Abstract][Full Text] [Related]
11. SRp20 and CUG-BP1 modulate insulin receptor exon 11 alternative splicing.
Sen S; Talukdar I; Webster NJ
Mol Cell Biol; 2009 Feb; 29(3):871-80. PubMed ID: 19047369
[TBL] [Abstract][Full Text] [Related]
12. Characterization and cloning of the human splicing factor 9G8: a novel 35 kDa factor of the serine/arginine protein family.
Cavaloc Y; Popielarz M; Fuchs JP; Gattoni R; Stévenin J
EMBO J; 1994 Jun; 13(11):2639-49. PubMed ID: 8013463
[TBL] [Abstract][Full Text] [Related]
13. Alternative splicing of intron 3 of the serine/arginine-rich protein 9G8 gene. Identification of flanking exonic splicing enhancers and involvement of 9G8 as a trans-acting factor.
Lejeune F; Cavaloc Y; Stevenin J
J Biol Chem; 2001 Mar; 276(11):7850-8. PubMed ID: 11096110
[TBL] [Abstract][Full Text] [Related]
14. Mapping the SF2/ASF binding sites in the bovine growth hormone exonic splicing enhancer.
Dirksen WP; Li X; Mayeda A; Krainer AR; Rottman FM
J Biol Chem; 2000 Sep; 275(37):29170-7. PubMed ID: 10880506
[TBL] [Abstract][Full Text] [Related]
15. An intron enhancer recognized by splicing factors activates polyadenylation.
Lou H; Gagel RF; Berget SM
Genes Dev; 1996 Jan; 10(2):208-19. PubMed ID: 8566754
[TBL] [Abstract][Full Text] [Related]
16. Arginine/serine-rich protein interaction domain-dependent modulation of a tau exon 10 splicing enhancer: altered interactions and mechanisms for functionally antagonistic FTDP-17 mutations Delta280K AND N279K.
D'Souza I; Schellenberg GD
J Biol Chem; 2006 Feb; 281(5):2460-9. PubMed ID: 16308321
[TBL] [Abstract][Full Text] [Related]
17. Structural, functional, and protein binding analyses of bovine papillomavirus type 1 exonic splicing enhancers.
Zheng ZM; He PJ; Baker CC
J Virol; 1997 Dec; 71(12):9096-107. PubMed ID: 9371566
[TBL] [Abstract][Full Text] [Related]
18. Exonic splicing enhancer motif recognized by human SC35 under splicing conditions.
Liu HX; Chew SL; Cartegni L; Zhang MQ; Krainer AR
Mol Cell Biol; 2000 Feb; 20(3):1063-71. PubMed ID: 10629063
[TBL] [Abstract][Full Text] [Related]
19. The splicing factor SRp20 modifies splicing of its own mRNA and ASF/SF2 antagonizes this regulation.
Jumaa H; Nielsen PJ
EMBO J; 1997 Aug; 16(16):5077-85. PubMed ID: 9305649
[TBL] [Abstract][Full Text] [Related]
20. Activation of alpha-tropomyosin exon 2 is regulated by the SR protein 9G8 and heterogeneous nuclear ribonucleoproteins H and F.
Crawford JB; Patton JG
Mol Cell Biol; 2006 Dec; 26(23):8791-802. PubMed ID: 17000773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]